<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Revive Therapeutics Expands into Phase III Clinical Trials
Image Overlay - Revive Therapeutics Expands into Phase III Clinical Trials

Revive Therapeutics Expands into Phase III Clinical Trials

Revive Therapeutics Expands into Phase III Clinical Trials

Revive Therapeutics will expand their candidate, Bucillamine, in patients with mild-moderate COVID-19 in phase III trials taking place in the Asia-Pacific Countries (“APAC”) and Canada. Revive expects to open the Phase 3 clinical trial for patient enrollment and dosing in September 2020. Yourway has a depot in Mississauga, Ontario in Canada, as well as in Beijing, China, Tokyo, Japan, Singapore, and Adelaide, Australia.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Precision in Pharma Supply Chain Summit Boston

November 16-17, 2026
Boston, MA

SCOPE Supply Chain & Logistics Leadership Summit

March 1-4, 2027
Orlando, FL

Media

Articles

Promises Start Partnerships. Performance Builds Them.

Open chat
Come chat with us!
Hello! How can I help you?